Free Trial
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

Pro-Dex logo
$47.71 +2.66 (+5.90%)
As of 07/3/2025 03:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Pro-Dex Stock (NASDAQ:PDEX)

Key Stats

Today's Range
$45.18
$47.91
50-Day Range
$39.00
$69.00
52-Week Range
$17.02
$70.26
Volume
27,791 shs
Average Volume
35,964 shs
Market Capitalization
$155.53 million
P/E Ratio
17.04
Dividend Yield
N/A
Price Target
$56.00
Consensus Rating
Buy

Company Overview

Pro-Dex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
49th Percentile Overall Score

PDEX MarketRank™: 

Pro-Dex scored higher than 49% of companies evaluated by MarketBeat, and ranked 1678th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Pro-Dex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Pro-Dex has only been the subject of 1 research reports in the past 90 days.

  • Read more about Pro-Dex's stock forecast and price target.
  • Earnings Growth

    Earnings for Pro-Dex are expected to grow by 3.00% in the coming year, from $2.00 to $2.06 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Pro-Dex is 17.04, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.56.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Pro-Dex is 17.04, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.60.

  • Price to Book Value per Share Ratio

    Pro-Dex has a P/B Ratio of 5.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Pro-Dex's valuation and earnings.
  • Percentage of Shares Shorted

    7.86% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pro-Dex has recently increased by 6.21%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Pro-Dex does not currently pay a dividend.

  • Dividend Growth

    Pro-Dex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.86% of the float of Pro-Dex has been sold short.
  • Short Interest Ratio / Days to Cover

    Pro-Dex has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Pro-Dex has recently increased by 6.21%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Pro-Dex has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • Search Interest

    Only 1 people have searched for PDEX on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Pro-Dex to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Pro-Dex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    47.50% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 15.28% of the stock of Pro-Dex is held by institutions.

  • Read more about Pro-Dex's insider trading history.
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

PDEX Stock News Headlines

Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks.
See More Headlines

PDEX Stock Analysis - Frequently Asked Questions

Pro-Dex's stock was trading at $46.75 at the beginning of the year. Since then, PDEX stock has increased by 2.1% and is now trading at $47.71.

Pro-Dex, Inc. (NASDAQ:PDEX) issued its quarterly earnings data on Thursday, May, 1st. The medical instruments supplier reported $0.98 earnings per share for the quarter, topping analysts' consensus estimates of $0.47 by $0.51. The medical instruments supplier had revenue of $17.41 million for the quarter, compared to the consensus estimate of $17.70 million. Pro-Dex had a trailing twelve-month return on equity of 29.08% and a net margin of 14.61%.

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL).

Company Calendar

Last Earnings
5/01/2025
Today
7/04/2025
Next Earnings (Estimated)
9/04/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PDEX
Employees
140
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$56.00
High Stock Price Target
$56.00
Low Stock Price Target
$56.00
Potential Upside/Downside
+17.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
17.04
Forward P/E Ratio
23.86
P/E Growth
N/A
Net Income
$2.13 million
Pretax Margin
19.32%

Debt

Sales & Book Value

Annual Sales
$53.84 million
Cash Flow
$1.01 per share
Price / Cash Flow
47.05
Book Value
$9.03 per share
Price / Book
5.28

Miscellaneous

Free Float
1,712,000
Market Cap
$155.53 million
Optionable
Not Optionable
Beta
0.19

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:PDEX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners